The second workshop on Clinical and Laboratory Genomic and Genetic Standards will review progress since the 2004 Paris meeting in the development of standard controls, best practices and qualifying algorithms for microarray-based assays in clinical applications as well as consider what additional guidelines and materials could help accelerate drug and diagnostic development.
This meeting is intended to serve as a forum for discussion of reference standards and guidelines as used in microarray-based assays to manage quality control, analytical reproducibility, algorithm qualification and failure analysis among stakeholders engaged in the drug and diagnostic pipeline including development, regulatory, and laboratory implementation.
This meeting is intended to serve as a forum for discussion of reference standards and guidelines as used in microarray-based assays to manage quality control, analytical reproducibility, algorithm qualification and failure analysis among stakeholders engaged in the drug and diagnostic pipeline including development, regulatory, and laboratory implementation.
